IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Kaiser Permanente
Essen Biotech
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
M.D. Anderson Cancer Center
Mayo Clinic
University Health Network, Toronto
Cancer Research UK
University Health Network, Toronto
Cancer Research UK
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
Hadassah Medical Organization
Washington University School of Medicine
Cancer Research UK
University of Virginia
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Region Skane
University of Alberta
Stanford University
University Health Network, Toronto
Stanford University
University of Toronto
Second Affiliated Hospital of Guangzhou Medical University
Cancer Support Community, Research and Training Institute, Philadelphia
Memorial Sloan Kettering Cancer Center
Hefei TG ImmunoPharma Co., Ltd.
Centro di Riferimento Oncologico - Aviano
Herlev Hospital
Institut de Cancérologie de Lorraine
Scripps Health
Ludwig Institute for Cancer Research
Istituto Clinico Humanitas
Imperial College London
Duke University
Roswell Park Cancer Institute
University of Dundee
Shanghai Fengxian District Central Hospital
University of Manchester
Hospices Civils de Lyon
Mie University
Cambridge University Hospitals NHS Foundation Trust